Skip to main content

4 Result(s)

within William R. Lewis Remove this filter

and

  1. Article

    Open Access

    Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

    Novel oral anticoagulants (NOACs) have been approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). A large number of patients are on NOACs when they p...

    Ajay Vallakati, Abhishek Sharma, Mohammed Madmani, Madhu Reddy… in Cardiology and Therapy (2016)

    Download PDF (2406 KB) View Article

  2. No Access

    Chapter

    Case 9

    The patient is a 55-year-old male with a history of hypertension, left ventricular hypertrophy, and paroxysmal atrial fibrillation (AF) since 2001; both Flecainide and Sotalol had failed.

    Alberto Diaz, Dimpi Patel, William R. Lewis, Andrea Natale in Cardiac Electrophysiology (2011)

  3. No Access

    Chapter

    Case 58

    A 22-year-old male with no significant medical history presented with recurrent palpitations, dizziness, and chest discomfort. The patient reports having symptoms of shortness of breath and fatigue. He is curr...

    Roopinder Sandhu, Dimpi Patel, William R. Lewis, Andrea Natale in Cardiac Electrophysiology (2011)

  4. No Access

    Article

    Rational patient selection for catheter ablation of atrial fibrillation

    During the past decade, catheter ablation of atrial fibrillation has been progressively used for the treatment of drug-refractory patients. As experience and technique have evolved, patient selection criteria ...

    Roopinder K. Sandhu, Luigi Di Biase, William R. Lewis… in Current Cardiology Reports (2009)